Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Functional Protein

Recombinant Human KIR3DS1/CD158e2 Protein, C-hFc-His (Active)

Catalog #:   AHG92701 Specific References (50) DATASHEET
Applications: Bioactivity, ELISA, Immunogen, SDS-PAGE, WB
Expression system: Mammalian Cells
Accession: Q14943
Protein length: His22-His340
Overview

Catalog No.

AHG92701

Biological activity

Measured by its ability to bind HLA on human breast cancer cells (MDA‑MB‑231). The ED50 for this effect is 0.03-0.18 μg/mL.

Expression system

Mammalian Cells

Species

Homo sapiens (Human)

Protein length

His22-His340

Nature

Recombinant

Endotoxin level

<0.1 EU/μg of the protein by the LAL method.

Purity

>90% as determined by SDS-PAGE.

Accession

Q14943

Applications

Bioactivity, ELISA, Immunogen, SDS-PAGE, WB

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 5% Trehalose, 5% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for one week. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Killer cell immunoglobulin-like receptor 3DS1, MHC class I NK cell receptor, NKAT-10, NKAT10, KIR3DS1, Natural killer-associated transcript 10

Data Image
References

The Impact of Killer Cell Immunoglobulin-Like Receptors and Human Leukocyte Antigen-E, Human Leukocyte Antigen-G Polymorphisms on Innate Immunity and COVID-19 Severity., PMID:40391199

Association of killer cell immunoglobulin-like receptor genes with primary Sjögren's syndrome among Chinese population., PMID:39947039

Identification of four novel KIR alleles in haematopoietic stem cell donors of Indian origin., PMID:39162080

Killer-cell immunoglobulin-like receptor polymorphism is associated with COVID-19 outcome: Results of a pilot observational study., PMID:39148254

Activating KIR/HLA-I combinations as a risk factor of adult B-ALL., PMID:38262874

High-resolution characterization of KIR genes polymorphism in healthy subjects from the Bulgarian population-A pilot study., PMID:38180282

Donor aKIR genes influence the risk of EBV and CMV reactivation after anti-thymocyte globulin-based haploidentical hematopoietic stem cell transplantation., PMID:38081622

HLA-F and LILRB1 Genetic Polymorphisms Associated with Alloimmunisation in Sickle Cell Disease., PMID:37686397

Evaluation of KIR3DL1/KIR3DS1 allelic polymorphisms in Kenyan children with endemic Burkitt lymphoma., PMID:37647275

Association of killer cell immunoglobulin-like receptors and their cognate HLA class I ligands with susceptibility to acute myeloid leukemia in Iranian patients., PMID:37454198

Killer cell immunoglobulin-like receptor (KIR) genes and their HLA ligands in a Brazilian population., PMID:37350049

Expression profile of KIR3DS1/KIR3DL1 receptors in association with immunological responses in TB, HIV and HIV/TB infected patients., PMID:37169313

HLA-F transcriptional and protein differential expression according to its genetic polymorphisms., PMID:37166140

KIR genotype and haplotype repertoire in Kuwaiti healthy donors, hematopoietic cell transplant recipients and healthy family members., PMID:36960942

Co-Expression Analysis of Airway Epithelial Transcriptome in Asthma Patients with Eosinophilic vs. Non-Eosinophilic Airway Infiltration., PMID:36835202

Killer cell immunoglobulin-like receptor three domains long cytoplasmic tail 1 gene *007 may modulate disease progression of human immunodeficiency virus-1 infection in the Japanese population., PMID:36807537

The impact of killer cell immunoglobulin-like receptor (KIR) genes and human leukocyte antigen (HLA) class I ligands on predisposition or protection against prostate cancer., PMID:36599262

Understanding the killer-cell immunoglobulin like receptor polymorphism in retinoblastoma., PMID:36594723

KIR-HLA gene diversities and susceptibility to lung cancer., PMID:36241658

Killer-Cell Immunoglobulin-like Receptor Diversity in an Admixed South American Population., PMID:36139351

Mobilisation of HLA-F on the surface of bronchial epithelial cells and platelets in asthmatic patients., PMID:35988034

Allele imputation for the killer cell immunoglobulin-like receptor KIR3DL1/S1., PMID:35192601

Evaluation of telomeric KIR genes and their association with CMV infection in kidney transplant recipients., PMID:35091752

A Genome-Wide CRISPR/Cas9-Based Screen Identifies Heparan Sulfate Proteoglycans as Ligands of Killer-Cell Immunoglobulin-Like Receptors., PMID:34917099

Donor activating killer cell immunoglobulin-like receptors genes correlated with Epstein-Barr virus reactivation after haploidentical haematopoietic stem cell transplantation., PMID:34787307

KIR3DS1 directs NK cell-mediated protection against human adenovirus infections., PMID:34533978

Large-Scale Imputation of KIR Copy Number and HLA Alleles in North American and European Psoriasis Case-Control Cohorts Reveals Association of Inhibitory KIR2DL2 With Psoriasis., PMID:34177931

Dynamic mRNA expression of donor-derived activating KIR genes and their significant effects on clinical outcome after haematopoietic stem cell transplantation., PMID:34085290

Activating Killer-Cell Immunoglobulin-Like Receptors Are Associated With the Severity of Coronavirus Disease 2019., PMID:33928374

Natural killer cells play an important role in virus infection control: Antiviral mechanism, subset expansion and clinical application., PMID:33887436

Diversity of KIR genes and their HLA-C ligands in Ugandan populations with historically varied malaria transmission intensity., PMID:33632228

Upregulation of HLA-F expression by BK polyomavirus infection induces immune recognition by KIR3DS1-positive natural killer cells., PMID:33359499

The Loss of HLA-F/KIR3DS1 Ligation Is Mediated by Hemoglobin Peptides., PMID:33126487

Association of killer-cell immunoglobulin-like receptor genes with acute myelogenous leukaemia., PMID:32767509

Resistance of KIR Ligand-Missing Leukocytes to NK Cells In Vivo in Patients with Acquired Aplastic Anemia., PMID:32680908

The effect of KIR and HLA polymorphisms on dengue infection and disease severity in northeastern Thais., PMID:32524212

Diversity of KIR/HLA Genotypes and Their Association with Psoriasis Vulgaris in the Western Mexican Population., PMID:32235781

Killer Cell Immunoglobulin-Like Receptor Genotypes and Haplotypes Contribute to Susceptibility to Hepatitis B Virus and Hepatitis C Virus Infection in Cameroon., PMID:31977279

Study of KIR gene expression at the mRNA level in specific donor-derived NK cells after allogeneic HSCT., PMID:31900503

Role of Killer cell immunoglobulin-like receptors (KIR) genes in stages of HIV-1 infection among patients from Burkina Faso., PMID:31863692

Activating killer cell immunoglobulin-like receptors: Detection, function and therapeutic use., PMID:31755661

HLA-F Allele-Specific Peptide Restriction Represents an Exceptional Proteomic Footprint., PMID:31717259

KIR3DL1/S1 Allotypes Contribute Differentially to the Development of Behçet Disease., PMID:31405953

Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study., PMID:31337191

The Role of Killer Immunoglobulin-Like Receptor Genes in Susceptibility to HIV-1 Infection and Disease Progression: A Meta-Analysis., PMID:31288555

HLA-F on Autologous HIV-Infected Cells Activates Primary NK Cells Expressing the Activating Killer Immunoglobulin-Like Receptor KIR3DS1., PMID:31270222

Activating KIRs on Educated NK Cells Support Downregulation of CD226 and Inefficient Tumor Immunosurveillance., PMID:31239317

Decreased interferon-γ production by NK cells from KIR haplotype B carriers in hepatitis C virus infection., PMID:31177636

Fluctuating and Geographically Specific Selection Characterize Rapid Evolution of the Human KIR Region., PMID:31156615

The Emerging Roles of Human Leukocyte Antigen-F in Immune Modulation and Viral Infection., PMID:31134067

Datasheet
$ 360
Product specifications
50 μg 360 100 μg 580

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human KIR3DS1/CD158e2 Protein, C-hFc-His (Active) [AHG92701]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only